PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

Is the FDA Summit about Online Opioid Sales or Opposing Drug Importation?

Americans censored from affordable insulin

For years, the pharmaceutical industry and the FDA have used the global problem of counterfeit drugs to lobby against importation of lower-cost prescription medicines. They have used the online sale of controlled drugs without a prescription as a pretext to curtail online access to licensed pharmacies in Canada. And now they’re using the opioid addiction and overdose crisis as well. So, when I learned that there will be a meeting hosted by the FDA, a “Summit” to address the problem, my radar went up. What is this really about, and who has a seat at the table?

The event is called “FDA Online Opioid Summit: Reducing Availability of Illicit Opioids Online.” I have no doubt that the participants genuinely want to stop illegal opioid sales on social media sites and rogue pharmacy sites, but Panel #1 is essentially the usual pharma suspects from the Alliance for Safe Online Pharmacies, who spent about half a million bucks lobbying Congress to stop prescription importation legislation that doesn’t even allow imports of controlled substances at all. Since 2009, that group has been pushed by Eli Lilly on the Obama administration to shut down safe international pharmacies under the guise of going after rogue sites and counterfeiters. (more…)

Share
Tagged with: , ,

Dr. Kristina Acri’s Blatantly Misleading Op-Ed Opposing State Drug Importation Bill

drug pricesThe relentless deluge of Big Pharma bunk in the media continues. Dr. Kristina Acri, an associate professor of economics at Colorado College, recently published an op-ed in a local Colorado newspaper – The Pueblo Chieftain – called “Drug importation bill a poison pill.” Dr. Acri is against a state bill supported by Congressman Jared Polis (D-CO), who is also running for Governor, that would allow the wholesale importation of lower-cost medication from Canada. This bill is similar to one recently passed in Vermont, which came from drug importation model legislation created by the National Academy for State Health Policy.

The Pueblo Chieftain did not include that Dr. Acri has worked for the Pharmaceutical Researchers and Manufacturers of America. She is also known as a staunch supporter of the drug industry’s intellectual property rights agenda.

Congressman Polis was given ample opportunity to respectfully refute Dr. Acri’s stance in his own op-ed calledA safe way to lower drug costs.” I liked his op-ed. Feel free to read both of their positions, but one thing he wrote about Dr. Acri’s piece was wrong: “I very much appreciate Dr. Acri offering a constructive, fact-based critique that enriches our community’s discussion of this important issue.” Her piece was decidedly not fact-based, and it needs to be called out. Let’s break it down.

First, she writes: A study by the Organization of Economic Co-Operation and Development showed that counterfeit drugs accounted for 2.5 percent – or $461 billion— of the world drug market in 2013.” I looked at that report, and it states that in 2013 international trade in counterfeit and pirated goods (not just drugs) “represented up to 2.5% of world trade, or as much as $461 billion.” That section is referring to total world trade – not solely pharmaceuticals. That total includes all counterfeit products ranging from “high-end consumer luxury goods such as watches, perfumes or leather goods, to business-to-business products such as toys, pharmaceuticals, cosmetics and foodstuffs.” Over the years, the industry has plucked numbers out of thin are on the topic of counterfeit drugs, getting “facts” to stick in the media, but this one really took the cake.

See the study for yourself: https://read.oecd-ilibrary.org/governance/trade-in-counterfeit-and-pirated-goods_9789264252653-en#page12. (more…)

Share
Tagged with: , , , ,

Building Support for Safe Online Access to Affordable Medicines at RightsCon 2018

From left to right: Aria Iliad Ahmad, me, Dr. Jillian Clare Kohler, Tim Smith, Ron Andruff, Dr. Shivam Patel, Tracy Cooley, and Robert Guerra.

Last year I organized a panel at a conference called RightsCon to bring together Internet freedom and medicines rights activists to talk about buying medication online. And last week, I participated on a panel at RightsCon in Toronto that continued and strengthened those initial efforts. It was an honor to be on that panel, especially to hold discussions with academic experts in pharmaceutical safety and access with important roles working with the World Health Organization (WHO).

For those of you who are new to this blog, the work at RightsCon is directly relevant to PharmacyChecker’s mission to inform patients about safe and lower-cost medication options available on the Internet. Essentially, large pharmaceutical companies are lobbying governments and Internet companies to take actions that will prevent you from getting less expensive medications. This is also an issue about free speech and Internet freedom that should increasingly attract even more digital rights activists. Big Pharma is pressuring governments to pressure Internet gatekeepers to take down content. This is the Stop Online Piracy Act by a thousand cuts. We are trying to push back against that.

RightsCon is an annual conference focusing on the intersection of human rights and digital rights (issues related to the Internet). Access to medication has become an important issue at the United Nations, including by the Human Rights Council, which passed a resolution in 2016 declaring access to essential medicines a human right. Also, the UN convened a panel in 2016 dedicated to this issue, called the UN High Level Panel on Access to Medicines. Thus, the title of this year’s panel was Making Safe Online Access to Affordable Medication Real: Address the UN Human Rights resolution for access to essential medicines. (more…)

Share
Tagged with: , , , , , , , ,